Literature DB >> 20390474

Mechanisms of illness progression in the recurrent affective disorders.

Robert M Post1.   

Abstract

Along with genetic vulnerability, multiple environmental factors convey liability to illness progression, including: (1) distal and proximal stressors; (2) recurrence of episodes; and (3) comorbid cocaine abuse. Recurrence of each of these can increase responsivity (sensitize) to themselves and cross-sensitize to the two other factors and drive illness progression as seen clinically in increases in cycle acceleration, severity or duration of episodes, treatment refractoriness, disability, cognitive dysfunction, and premature death. Some mechanisms appear common to all three types of sensitization, such as decreases of brain-derived neuroprotective factor (BDNF) in hippocampus and blood, as well as increases in BDNF in the nucleus accumbens, suggesting the possibility that single treatments could ameliorate several of these factors at once. A potential example is N-acetylcysteine (NAC), which decreases bipolar affective illness severity (Berk et al. Biol Psychiatry 64:468–475, 2008) and cocaine reinstatement and craving (Baker et al. Ann N Y Acad Sci 1003:349–351, 2003; LaRowe et al. Am J Addict 15:105–110, 2006). Mechanisms of illness progression also involve epigenetic changes and add further rationale to the existing empirical clinical evidence of the importance of early recognition, treatment, and prevention of affective episodes. Adequate treatment could prevent or ameliorate both the increases in pathological factors and erosion of adaptive factors that propel illness exacerbation and treatment resistance. This view of the sensitization and cross-sensitization among stressors, episodes, and abused substances should lead to a fundamental re-conceptualization of the recurrent affective disorders not as benign, isolated episodes of “mental” illness, but as severe, potentially progressive and lethal medical disorders of brain and body that deserve careful life-long monitoring and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20390474     DOI: 10.1007/s12640-010-9182-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  77 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  Progressive behavioral changes during chronic lidocaine administration: relationship to kindling.

Authors:  R M Post; R T Kopanda; A Lee
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

3.  Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders.

Authors:  Brenda E Benson; Mark W Willis; Terence A Ketter; Andrew Speer; Tim A Kimbrell; Mark S George; Peter Herscovitch; Robert M Post
Journal:  Psychiatry Res       Date:  2008-09-17       Impact factor: 3.222

4.  Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

Authors:  G J Moore; J M Bebchuk; K Hasanat; G Chen; N Seraji-Bozorgzad; I B Wilds; M W Faulk; S Koch; D A Glitz; L Jolkovsky; H K Manji
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

5.  Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis.

Authors:  K S Kendler; L M Thornton; C O Gardner
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

6.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

7.  CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum.

Authors:  Amir A Levine; Zhonghui Guan; Angel Barco; Shiqin Xu; Eric R Kandel; James H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

8.  Lithium treatment and risk of dementia.

Authors:  Lars Vedel Kessing; Lars Søndergård; Julie Lyng Forman; Per Kragh Andersen
Journal:  Arch Gen Psychiatry       Date:  2008-11

Review 9.  Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena.

Authors:  Robert M Post
Journal:  Neurosci Biobehav Rev       Date:  2007-04-24       Impact factor: 8.989

10.  Mania-like behavior induced by disruption of CLOCK.

Authors:  Kole Roybal; David Theobold; Ami Graham; Jennifer A DiNieri; Scott J Russo; Vaishnav Krishnan; Sumana Chakravarty; Joseph Peevey; Nathan Oehrlein; Shari Birnbaum; Martha H Vitaterna; Paul Orsulak; Joseph S Takahashi; Eric J Nestler; William A Carlezon; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

View more
  20 in total

Review 1.  Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment.

Authors:  Trevor Archer; Richard M Kostrzewa; Tomas Palomo; Richard J Beninger
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 2.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

3.  Mindfulness-based cognitive therapy improves emotional reactivity to social stress: results from a randomized controlled trial.

Authors:  Willoughby B Britton; Ben Shahar; Ohad Szepsenwol; W Jake Jacobs
Journal:  Behav Ther       Date:  2011-10-01

Review 4.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

5.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

6.  Selective breeding for magnitude of methamphetamine-induced sensitization alters methamphetamine consumption.

Authors:  Angela C Scibelli; Carrie S McKinnon; Cheryl Reed; Sue Burkhart-Kasch; Na Li; Harue Baba; Jeanna M Wheeler; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

Review 7.  Neuroendocrine Stress System in Bipolar Disorder.

Authors:  Mario F Juruena; Anthony J Cleare; Allan H Young
Journal:  Curr Top Behav Neurosci       Date:  2021

8.  Running wheel activity restores MPTP-induced functional deficits.

Authors:  Anders Fredriksson; Ingels Maria Stigsdotter; Anders Hurtig; Béatrice Ewalds-Kvist; Trevor Archer
Journal:  J Neural Transm (Vienna)       Date:  2010-09-18       Impact factor: 3.575

9.  Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum; Mark Gold
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-30

10.  Epigenetic Modulation of Mood Disorders.

Authors:  T Archer; M Oscar-Berman; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.